U.S., Feb. 1 -- ClinicalTrials.gov registry received information related to the study (NCT06803680) titled 'A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors' on Jan. 27.
Brief Summary: The goal of this clinical trial is to learn if BGB-B455 can treat advanced or metastatic solid tumors expressing claudin 6 (CLDN6), a protein that is found on some tumors.
The main questions it aims to answer are:
* What is the recommended dosing for BGB-B455?
* What medical problems do participants have when taking BGB-B455?
The study has two parts:
* Phase 1a: dose escalation and safety expansion
* Phase 1b: dose expansion
Study Start Date: March, 2025
Study Type: INTERVENTIONAL
Condition:
Advanced Solid Tumor
Metastatic Sol...